ArticleFolia microbiologica2025
Anti-biofilm potential of Matricaria chamomilla against tetra species representative gut commensals.
Article in Folia microbiologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we investigated the effects of supratherapeutic concentrations of M. chamomilla extract on a tetra-species biofilm model comprising Escherichia coli, Enterococcus faecalis, Lactobacillus plantarum, and Lactobacillus fermentum. Phytochemical screening and GC–MS analysis revealed multiple bioactive compounds, including alkaloids and flavonoids, with potential anti-biofilm activity. Dose-dependent exposure to the extract resulted in a marked reduction in biofilm biomass and cell viability. At 30 µg/mL, biofilm inhibition reached approximately 52–80%, while viable cell counts decreased by more than 55%. FE-SEM confirmed distinct disruption of biofilm structure, and 16S rRNA sequencing indicated a decline in microbial diversity, with the Shannon index falling from 1.1 to 0.9 and observed OTUs decreasing from ~ 200 to ~ 150. These findings suggest that M. chamomilla is generally regarded as beneficial, excessive supplementation may adversely affect gut microbial composition and biofilm stability, highlighting the need for careful use under appropriate guidance.
Indexed as
Identifiers
41428150What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.